Peregrine Pharmaceuticals Enters Into Research Collaboration to…

Posted on by admin

Peregrine Pharmaceuticals, Inc. , a biopharmaceutical company focused on advancing bavituximab, a novel immuno-oncology agent in Phase III development for the treatment of lung cancer, today announced that the company has entered into a sponsored research agreement with Memorial Sloan Kettering Cancer Center to explore the potential of Peregrine’s proprietary phosphatidylserine -targeting antibody platform. The goal of the research is to identify effective treatment combinations based on Peregrine’s PS-targeting agents, including Peregrine’s lead clinical agent bavituximab, with other checkpoint inhibitors or immune stimulating agents that will further guide the bavituximab clinical development program.

SOURCE: Hospital Administration News – Read entire story here.

Related posts:

  1. Linking Uninsured Patients Treated In The Emergency Department To Primary Care Shows Some Promise In Maryland [Improving Care Systems] Use of the emergency department (ED) has increased significantly over the past twenty years, especially among people who lack access to regular care, such as from a primary care provider. Not only are many ED visits avoidable, but receiving care through the ED also may disrupt continuity of care and result in increased overall health care costs. This article analyzes one of the twenty-nine local projects funded by the Centers for Medicare and Medicaid Services: the Emergency Department–Primary Care Connect initiative of the Primary Care Coalition of Montgomery County, Maryland. The initiative linked low-income or uninsured patients with local safety-net...
  2. Statement on the retirement of The Children’s Inn Co-Founder and CEO Kathy Russell On behalf of everyone at the NIH, we wish you the very best as you begin your new chapter. Thank you for everything you’ve done for our patients and their families. ...
  3. Sleeping Aids and Diabetes People with diabetes certainly aren't immune to issues with insomnia or other sleeping problems that occur with age, jet lag or seasonal affective disorder. When that happens, sometimes counting sheep just doesn't cut it. But there has been concer... ...
  4. How our gut changes across the life course Scientists and clinicians on the Norwich Research Park have carried out the first detailed study of how our intestinal tract changes as we age, and how this determines our overall health. ...
  5. Why Obamacare Supporters Should Favor the Trump Administration’s Medicaid Block Grant Proposal Readers of this blog know that no one has been more critical of Obamacare’s flaws––particularly […] ...

Related Posts

Hospital News salutes Nursing Hero Nominee Shelley Wettlaufer

Shelley Wettlaufer. Shelley Wettlaufer – Mississauga Halton Community Care Access Centre I would like to nominate my nurse, and my colleague Shelley Wettlaufer whom I known for the last few months only. It is with great pleasure to nominate Shelley as an outstanding and dedicated person, who places the interests of our patients first and foremost. A registered nurse by trade, with current registration with CNO since 1995, Shelley is the team lead for West Community team with Mississauga Halton Community Care Access Centre (MHCCAC). She is also a care coordinator and the subject matter expert who provides a variety of support, advice, peer support and mentorship to her patients, team, other health care professionals involved in tertiary nursing care and also across MH CCAC. MORE: HOSPITAL NEWS

Some thoughts on overuse of sedatives, opiates, and stimulants

A recent article over at the Why is American Health Care So Expensive blog discussed the patterns in overuse of sedatives, opiates, and stimulants, noting:There is no good evidence that these medications are either safe or effective when used long term. In fact there is good evidence that they are NOT safe, and quite a bit of circumstantial evidence that they are not effective. We prescribe many times the number of controlled substances now than we did a decade ago, and overall Americans are not less anxious or less in pain or better able to concentrate than they were before. Those of us who prescribe opiates to patients with chronic pain very rarely see the pain become significantly more manageable though we do see the patients